These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33075094)

  • 1. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
    Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
    PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
    Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
    Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
    Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
    PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.
    Mutasa-Apollo T; Shiraishi RW; Takarinda KC; Dzangare J; Mugurungi O; Murungu J; Abdul-Quader A; Woodfill CJ
    PLoS One; 2014; 9(1):e86305. PubMed ID: 24489714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural Eswatini.
    Kerschberger B; Schomaker M; Ciglenecki I; Pasipamire L; Mabhena E; Telnov A; Rusch B; Lukhele N; Teck R; Boulle A
    Trop Med Int Health; 2019 Jun; 24(6):701-714. PubMed ID: 30938037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010.
    Takarinda KC; Harries AD; Shiraishi RW; Mutasa-Apollo T; Abdul-Quader A; Mugurungi O
    Int J Infect Dis; 2015 Jan; 30():98-105. PubMed ID: 25462184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV programmatic outcomes following implementation of the 'Treat-All' policy in a public sector setting in Eswatini: a prospective cohort study.
    Kerschberger B; Schomaker M; Jobanputra K; Kabore SM; Teck R; Mabhena E; Mthethwa-Hleza S; Rusch B; Ciglenecki I; Boulle A
    J Int AIDS Soc; 2020 Mar; 23(3):e25458. PubMed ID: 32128964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
    Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
    Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persons living with HIV with advanced HIV disease: need for novel care models.
    Teasdale CA; Yuengling K; Preko P; Syowai M; Ndagije F; Rabkin M; Abrams EJ; El-Sadr WM
    J Int AIDS Soc; 2018 Dec; 21(12):e25210. PubMed ID: 30549245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
    Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
    Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.
    Sabapathy K; Ford N; Chan KN; Kyaw MK; Elema R; Smithuis F; Floyd S
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e53-62. PubMed ID: 22334069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and early clinical outcomes of key populations attending comprehensive community-based HIV care: Experiences from Nasarawa State, Nigeria.
    Ibiloye O; Decroo T; Eyona N; Eze P; Agada P
    PLoS One; 2018; 13(12):e0209477. PubMed ID: 30571744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention on antiretroviral therapy during Universal Test and Treat implementation in Zomba district, Malawi: a retrospective cohort study.
    Alhaj M; Amberbir A; Singogo E; Banda V; van Lettow M; Matengeni A; Kawalazira G; Theu J; Jagriti MR; Chan AK; van Oosterhout JJ
    J Int AIDS Soc; 2019 Feb; 22(2):e25239. PubMed ID: 30734510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.
    Thida A; Tun ST; Zaw SK; Lover AA; Cavailler P; Chunn J; Aye MM; Par P; Naing KW; Zan KN; Shwe M; Kyaw TT; Waing ZH; Clevenbergh P
    PLoS One; 2014; 9(9):e108615. PubMed ID: 25268903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study.
    Shamu T; Chimbetete C; Egger M; Mudzviti T
    PLoS One; 2021; 16(6):e0253000. PubMed ID: 34106989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.